Company Data
Genenta Science S.p.A.
Ticker
GNTA
Current Price
$4.2 -2.33%
Market Cap
$76.8M
Price Target
Refer to Report
Volume
511
52wk Range
$2.79 - $7.28
Overview
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company’s product under development includes Temferon – a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.